title: Testing the hypothesis that vitamin C deficiency is a risk factor for clozapine-induced agranulocytosis using guinea pigs and ODS rats.
abstract: The use of clozapine is limited by a relatively high incidence of drug-induced agranulocytosis. Clozapine is oxidized by bone marrow cells to a reactive nitrenium ion. Although many idiosyncratic drug reactions are immune-mediated, the fact that patients with a history of clozapine-induced agranulocytosis do not immediately develop agranulocytosis on rechallenge suggests that some other factor may be responsible for the idiosyncratic nature of this reaction. The reactive nitrenium ion is very rapidly reduced back to clozapine by vitamin C, and many schizophrenic patients are vitamin C deficient. We set out to test the hypothesis that vitamin C deficiency is a major risk factor for clozapine-induced agranulocytosis using a vitamin C deficient guinea pig model. Although the vitamin C deficient guinea pigs did not develop agranulocytosis, the amount of clozapine covalent binding in these animals was less than we had previously observed in samples from rats and humans. Therefore, we studied ODS rats that also cannot synthesize vitamin C. Vitamin C deficient ODS rats also did not develop agranulocytosis, and furthermore, although covalent binding in the bone marrow was greater than that in the guinea pig, it was not increased in the vitamin C deficient ODS rats relative to ODS rats that had adequate vitamin C in their diet. Therefore, it is very unlikely that vitamin C deficiency is a major risk factor for clozapine-induced agranulocytosis.
authors.affiliation: Faculty of Pharmacy, University of Toronto, Toronto, Ontario M5S 3M2, Canada.
authors.forename: Julia
authors.initials: J
authors.lastname: Ip
authors.forename: John X
authors.initials: JX
authors.lastname: Wilson
authors.forename: Jack P
authors.initials: JP
authors.lastname: Uetrecht
mesh_terms: D000380:Agranulocytosis / Q000097:blood / Q000139:chemically induced*; D000818:Animals; D014150:Antipsychotic Agents / Q000009:adverse effects*; D001205:Ascorbic Acid / Q000097:blood; D001206:Ascorbic Acid Deficiency / Q000097:blood / Q000150:complications*; D003024:Clozapine / Q000009:adverse effects*; D005260:Female; D006168:Guinea Pigs; D007958:Leukocyte Count; D051381:Rats; D012307:Risk Factors
chemical_list: D014150:Antipsychotic Agents; D003024:Clozapine; D001205:Ascorbic Acid